{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:51:28Z","timestamp":1793116288598,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.atherosclerosis.2023.05.014","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T11:26:48Z","timestamp":1684927608000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis"],"prefix":"10.1016","volume":"376","author":[{"given":"Simon","family":"Kraler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian A.","family":"Wenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Vykoukal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes F.","family":"Fahrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Kun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nanchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Liberale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni G.","family":"Camici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Akhmedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Huang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","article-title":"Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis","volume":"396","author":"Narula","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamacardio.2017.1213","article-title":"Association between skin and aortic vascular inflammation in patients with psoriasis: a case-cohort study using positron emission tomography\/computed tomography","volume":"2","author":"Dey","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/EDE.0000000000001469","article-title":"The case for case-cohort: an applied epidemiologist's guide to reframing case-cohort studies to improve usability and flexibility","volume":"33","author":"O'Brien","year":"2022","journal-title":"Epidemiology"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomet\/73.1.1","article-title":"A case-cohort design for epidemiologic cohort studies and disease prevention trials","volume":"73","author":"Prentice","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0895-4356(99)00102-X","article-title":"Analysis of case-cohort designs","volume":"52","author":"Barlow","year":"1999","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib6","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/eurheartj\/ehy319","article-title":"Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths","volume":"39","author":"Ruuth","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.ATV.18.6.876","article-title":"Sialic acid content of LDL in coronary artery disease: no evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction, Arterioscler","volume":"18","author":"Chappey","year":"1998","journal-title":"Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/01.ATV.16.8.1040","article-title":"Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B","volume":"16","author":"Capell","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and investigators, evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib10","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.amjcard.2014.12.006","article-title":"Investigators of National Registry of Myocardial Infarction (NRMI) 4b\u20135, Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox)","volume":"115","author":"Reddy","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib12","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib13","first-page":"978","article-title":"CCC-ACS Investigators, Revisiting the lipid paradox in ST-elevation myocardial infarction in the Chinese population: findings from the CCC-ACS project","volume":"10","author":"Sun","year":"2021","journal-title":"Eur. Hear. Journal. Acute Cardiovasc. Care."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham heart study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004425","article-title":"Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score","volume":"4","author":"Fox","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib16","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/eurheartj\/ehac143","article-title":"Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1388-1981(00)00123-2","article-title":"Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL","volume":"1488","author":"Hevonoja","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120550","article-title":"Molecular and cellular mechanisms of electronegative lipoproteins in cardiovascular diseases","volume":"8","author":"Ke","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/CIRCRESAHA.108.190116","article-title":"Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis","volume":"104","author":"Lu","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib20","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1182\/blood-2013-05-504639","article-title":"Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation","volume":"122","author":"Chan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib21","first-page":"6736","article-title":"Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation","author":"Wenzl","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib22","doi-asserted-by":"crossref","DOI":"10.1214\/aos\/1176350691","article-title":"Asymptotic distribution theory and efficiency results for case-cohort studies","volume":"16","author":"Self","year":"1988","journal-title":"Ann. Stat."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1009691327335","article-title":"Computing the Cox model for case cohort designs","volume":"5","author":"Therneau","year":"1999","journal-title":"Lifetime Data Anal."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib25","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/01.CIR.0000065220.70220.F7","article-title":"Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription","volume":"107","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-Regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1194\/jlr.S120001025","article-title":"Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures","volume":"61","author":"Liebisch","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib28","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaa375","article-title":"Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction","volume":"42","author":"Hung","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2307\/2533444","article-title":"Robust variance estimation for the case-cohort design","volume":"50","author":"Barlow","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","article-title":"Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians","volume":"19","author":"Carpenter","year":"2000","journal-title":"Stat. Med."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib31","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1093\/bioinformatics\/bty344","article-title":"MetaboDiff: an R package for differential metabolomic analysis","volume":"34","author":"Mock","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz430","article-title":"Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Guedeney","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib34","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.ATV.20.7.1777","article-title":"Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements","volume":"20","author":"Gierens","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.116.304653","article-title":"Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction","volume":"116","author":"Liebetrau","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2015.10.023","article-title":"Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: a time-trend analysis","volume":"172","author":"Sara","year":"2016","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib37","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0022-2275(20)32533-5","article-title":"Femtomole analysis of 9-oxononanoyl cholesterol by high performance liquid chromatography","volume":"39","author":"Karten","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib38","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M019174","article-title":"Electrospray MS\/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions","volume":"52","author":"Hutchins","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2023.05.014_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/01.ATV.0000012782.59850.41","article-title":"Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1\/2 pathway","volume":"22","author":"Huber","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023002071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023002071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:51:56Z","timestamp":1758156716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023002071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":39,"alternative-id":["S0021915023002071"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.05.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}